Compare BIO & CHRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | CHRD |
|---|---|---|
| Founded | 1952 | 2007 |
| Country | United States | United States |
| Employees | 7450 | 676 |
| Industry | Biotechnology: Laboratory Analytical Instruments | Oil & Gas Production |
| Sector | Industrials | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 8.2B |
| IPO Year | N/A | N/A |
| Metric | BIO | CHRD |
|---|---|---|
| Price | $295.29 | $112.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 13 |
| Target Price | ★ $339.75 | $149.17 |
| AVG Volume (30 Days) | 318.0K | ★ 859.7K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.74 | $12.56 |
| Revenue Next Year | $3.20 | N/A |
| P/E Ratio | ★ $9.72 | $34.53 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $236.73 | $84.25 |
| 52 Week High | $343.12 | $151.95 |
| Indicator | BIO | CHRD |
|---|---|---|
| Relative Strength Index (RSI) | 53.85 | 28.76 |
| Support Level | $293.88 | $86.73 |
| Resistance Level | $312.51 | $150.29 |
| Average True Range (ATR) | 9.55 | 3.37 |
| MACD | 0.52 | -1.12 |
| Stochastic Oscillator | 72.06 | 6.53 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Chord Energy Corp is an independent exploration and production (E&P) company engaged in the acquisition, exploration, development and production of crude oil, NGL and natural gas prominently in the Williston Basin, with limited non-operated interests in the Marcellus Shale. It operates in one reportable business segment, which is the E&P of crude oil, NGL and natural gas. The company derives revenue from the sale of crude oil, NGL and natural gas production.